US Stock Futures Signal Lower Start On Wall Street
US stock futures traded lower in early pre-market trade. Futures for the Dow Jones Industrial Average dropped 31 points to 17,830.00, while the Standard & Poor's 500 index futures fell 3.50 points to 2,067.30. Futures for the Nasdaq 100 index declined 6.25 points to 4,398.75.
A Peek Into Global Markets
European markets were lower today, with the Spanish Ibex Index falling 0.45%, STOXX Europe 600 Index declining 0.52% and German DAX 30 index dropping 0.20%. French CAC 40 Index slipped 0.44% and London's FTSE 100 Index fell 1.30%.
In Asian markets, Japan's Nikkei Stock Average fell 0.95%, Hong Kong's Hang Seng Index dropped 0.17%, China's Shanghai Composite Index climbed 1.89% and India's BSE Sensex fell 2.05%.
Analysts at JMP Securities upgraded DR Horton (NYSE: DHI) from Market Perform to Market Outperform. The price target for DR Horton is set to $31.
DR Horton's shares fell 3.15% to close at $26.17 on Friday.
- Spectrum Pharmaceuticals (NASDAQ: SPPI) today announced that its New Drug Application (NDA) for Captisol-Enabled Melphalan (CE-Melphalan), has been accepted by the U.S. Food and Drug Administration (FDA). To read the full news, click here.
- Tuniu Corporation (NASDAQ: TOUR) today announced the acquisition of majority stakes in each of Zhejiang Zhongshan International Travel Services Co., LTD, a Hangzhou-based travel agency, and China Classical Holiday, a Tianjin-based travel agency. To read the full news, click here.
- TelecityGroup plc (OTC: TLCTF) and Interxion Holding N.V. (NYSE: INXN), each a provider of data centres in Europe, announce that they have entered into a definitive agreement on an all-share merger on the same terms as announced on 11 February 2015. To read the full news, click here.
- News Corp (NASDAQ: NWSA) announced the signing of a definitive agreement to acquire the VCCircle Network, which includes VCCircle.com, Techcircle.in, VCCEdge, VCCircle Training, in addition to a premium-content driven conference business. To read the full news, click here.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.